NGM Biopharmaceuticals Inc buy B. Riley
Start price
22.11.23
/
50%
€0.63
Target price
22.11.24
€3.22
Performance (%)
125.60%
End price
23.11.24
-
Summary
This prediction is currently being closed. The BUY prediction by B__Riley for NGM Biopharmaceuticals Inc has seen massive gains of 125.60%. B__Riley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| NGM Biopharmaceuticals Inc | - | - | - |
| iShares Core DAX® | 1,72 % | 3,37 % | 5,89 % |
| iShares Nasdaq 100 | -4,56 % | -4,24 % | 21,39 % |
| iShares Nikkei 225® | -7,12 % | -11,87 % | 42,36 % |
| iShares S&P 500 | -0,89 % | 1,69 % | 19,49 % |
Comments by B__Riley for this prediction
In the thread NGM Biopharmaceuticals Inc diskutieren
NGM Biopharmaceuticals, Inc. (NASDAQ: NGM) had its price target lowered by analysts at B. Riley from $7.00 to $3.50. They now have a "buy" rating on the stock.
Ratings data for NGM provided by MarketBeat
In the thread Trading NGM Biopharmaceuticals Inc
Die von B__Riley gewählte maximale Laufzeit wurde überschritten

